These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29893036)

  • 21. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
    Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
    Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative chemotherapy compared with postoperative adjuvant chemotherapy for squamous cell carcinoma of the thoracic oesophagus with the detection of circulating tumour cells randomized controlled trial.
    Zhao Y; Han L; Zhang W; Shan L; Wang Y; Song P; Peng C; Zhao X
    Int J Surg; 2020 Jan; 73():1-8. PubMed ID: 31756547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy.
    Yin XD; Yuan X; Xue JJ; Wang R; Zhang ZR; Tong JD
    Dis Esophagus; 2012; 25(8):750-6. PubMed ID: 22394149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
    Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
    Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
    Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
    PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
    Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
    Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
    J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
    Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma.
    Matsushita D; Uenosono Y; Arigami T; Yanagita S; Nishizono Y; Hagihara T; Hirata M; Haraguchi N; Arima H; Kijima Y; Kurahara H; Maemura K; Okumura H; Ishigami S; Natsugoe S
    Ann Surg Oncol; 2015 Oct; 22(11):3674-80. PubMed ID: 25652049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.
    Liu DG; Xue L; Li J; Yang Q; Peng JZ
    Cancer Biomark; 2018; 22(3):417-426. PubMed ID: 29758927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population.
    Rong L; Wang B; Guo L; Liu X; Wang B; Ying J; Xue L; Lu N
    Diagn Pathol; 2020 Mar; 15(1):27. PubMed ID: 32209107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.